BioCatalyst

Sacituzumab Govitecan-hziy, Pembrolizumab, Paclitaxel, nab-Paclitaxel — catalyst calendar

1 verified catalyst event(s) referencing Sacituzumab Govitecan-hziy, Pembrolizumab, Paclitaxel, nab-Paclitaxel, each linked to its official source. Verified as of 2026-10-02.

Upcoming

DateEventCompanyDrugOfficial source & verification
2027-02 (month)
in 4mo
ESTIMATED
 READOUT
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physic
Phase 3 · Triple Negative Breast Cancer, PD-L1 Positive
 GILD GILEAD SCIENCES, INC. Sacituzumab Govitecan-hziy, Pembrolizuma ClinicalTrials.gov ↗
✓ Source-checked 2026-10-02
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.